Finance

Lists
KTTAW:NASDAQ
Pasithea Therapeutics
$0.0035
0.00%
(0.00) 1D
$0.0035
0.00% (0.00)
Pre-market
Closed: Sep 9, 3:56:12 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for KTTAW...
Mkt. cap
18.03M
Avg. vol.
7.65K
Volume
0.00
52-wk high
$0.12
52-wk low
$0.00
Beta
0.79
No. of employees
5
Mkt. cap
18.03M
Avg. vol.
7.65K
Volume
0.00
52-wk high
$0.12
52-wk low
$0.00
Beta
0.79
No. of employees
5
About Pasithea Therapeutics
CEO-
Employees5
Founded2020
HeadquartersMiami Beach, Florida, United States
SectorBiotechnology
Analyst
Recommendation
Action
Price target
Projected
Date
No analyst ratings found.
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
1.36M
2.74M
2.94M
3.69M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.75M
3.35M
1.93M
2.03M
Operating expense
3.11M
6.09M
4.88M
5.71M
Total operating expenses
3.11M
6.09M
4.88M
5.71M
Operating income
-3.11M
-6.09M
-4.88M
-5.71M
Other non operating income
55.49K
-64.17K
1.57M
58.81K
EBT including unusual items
-3.04M
-10.11M
-2.87M
-5.27M
EBT excluding unusual items
-3.04M
-5.95M
-2.87M
-5.27M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-3.04M
-10.11M
-2.87M
-5.27M
Net profit margin
-
-
-
-
Earnings per share
-
-0.89
-0.12
-0.16
Interest and investment income
43.40K
182.13K
450.34K
410.42K
Interest expense
-
-
-
-
Net interest expenses
43.40K
182.13K
450.34K
410.42K
Depreciation and amortization charges
-
-
-
-
EBITDA
-2.93M
-5.93M
-4.72M
-5.56M
Gain or loss from assets sale
-
103.32K
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google apps